DWT
DXCM icon

Dorsey & Whitney Trust’s DexCom DXCM Stock Holding History

Dorsey & Whitney Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,204
Closed -$280K – 697
2025
Q2 		$280K Buy
+3,204
New +$251K 0.01% 554
2025
Q1 		– Sell
-4,296
Closed -$334K – 670
2024
Q4 		$334K Buy
+4,296
New +$318K 0.02% 486
2024
Q3 		– Sell
-3,216
Closed -$365K – 673
2024
Q2 		$365K Buy
3,216
+24
+0.8% +$3.03K 0.03% 410
2024
Q1 		$443K Buy
3,192
+37
+1% +$4.65K 0.03% 377
2023
Q4 		$392K Buy
+3,155
New +$322K 0.03% 391
2023
Q3 		– Sell
-2,418
Closed -$311K – 596
2023
Q2 		$311K Buy
+2,418
New +$292K 0.03% 425

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dorsey & Whitney Trust's DXCM Position: Q3 2025 in Review

Dorsey & Whitney Trust sold out of DexCom (DXCM) in Q3 2025, closing a stake of 3,204 shares — an estimated $280K sold.

Dorsey & Whitney Trust first reported a position in DXCM in Q2 2023 and held it in 6 quarters. The position peaked at $443K in Q1 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Dorsey & Whitney Trust reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 3,204 DexCom shares in Q3 2025, an estimated $280K.
  • Dorsey & Whitney Trust first reported a position in DexCom in Q2 2023 and held it in 6 quarters.
  • Dorsey & Whitney Trust's DexCom position peaked at $443K in Q1 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Dorsey & Whitney Trust's 13F filing for Q3 2025, filed 13 Nov 2025.